BWX Technologies (BWXT) said Monday its subsidiary BWXT Medical Ltd. and TRIUMF, Canada's particle accerlator center, entered a licensing and services...
BWX Technologies (BWXT) said Thursday it secured a contract from the Department of Defense Strategic Capabilities Office to build an advanced nuclear...
...
...
| Address | 800 Main Street Lynchburg, Virginia 24504-1533 |
| Phone | +1.980.365.4300 |
| Number of Employees | 6,250 |
| Recent SEC Filing | 06/09/2022 4 |
| President, Chief Executive Officer & Director | Rex D. Geveden |
| Chief Financial Officer & Senior Vice President | Robb A. LeMasters |
| Chief Technology Officer & Vice President | Jonathan W. Cirtain |
| Secretary, Chief Compliance Officer & Senior VP | Thomas E. McCabe |
| Price Open | $53.30 |
| Previous Close | $53.52 |
| 52 Week Range | $42.58 - 62.53 |
| Market Capitalization | $5.0 B |
| Shares Outstanding | 91.2 M |
| Sector | Utilities |
| Industry | Electric Utilities |
| Current Dividend / Yield | $0.22 / 1.64% |
| Dividend Ex-Date | 05/19/2022 |
| Dividend Pay-Date | 06/08/2022 |
| Dividend Yield 5 Year Average | N/A | Next Earnings Announcement | 08/01/2022 |
| Call Open Interest (1d)* |  |
| Put Open Interest (1d)* | |
| Call Volume (1d)* | |
| Put Volume (1d)* | |
| Put Call Open Interest Ratio (1d)* | |
| Put Call Volume Ratio (1d)* | |
| * Data delayed by up to 15 minutes |
| Price / Earnings | 16.93 |
| Earnings per Share | $3.16 |
| Beta vs. S&P 500 | N/A |
| Revenue | $1.8 B |
| Net Profit Margin | 13.88% |
| Return on Equity | 45.68% |
| Buy | |
| Overweight | |
| Hold | |
| Underweight | |
| Sell | |
Consensus Recommendation | |
